EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clearance Pathways for α‐Synuclein in Parkinson's Disease

Margaret S Ho iD

Journal of Neurochemistry · 2025-06 · 169 (6)

DOI: 10.1111/jnc.70124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 12.06.2025. Verfasst von Margaret S Ho. Beteiligte Einrichtung: Institute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Yang Ming Chiao Tung University, National Natural Science Foundation of China, National Science and Technology Council Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein aggregation and accumulation are hallmark features of neurodegenerative diseases. In Parkinson's disease, the progressive formation and propagation of α‐synuclein aggregates—found in Lewy bodies and Lewy neurites—are closely linked to widespread neuronal dysfunction, dopaminergic neuron loss, and the emergence of both motor and nonmotor symptoms, including anosmia, cognitive decline, and depression. Despite their pathological significance, the mechanisms underlying the formation, spread, and clearance of these aggregates remain incompletely understood. In this review, we examine the cellular and molecular pathways responsible for the elimination of protein aggregates in the diseased brain. We first summarize various experimental models of α‐synuclein pathology, followed by a discussion of the degradation mechanisms in neurons and glial cells under pathological conditions. These findings offer new insights into cell type‐specific clearance pathways and highlight potential therapeutic targets for mitigating α‐synuclein–associated toxicity in Parkinson's disease. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansAnimalsLewy BodiesBrain

Stichwörter der Autor:innen

Parkinson's diseaseUPSautophagydegradationα‐Synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Institute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Margaret S Ho

Förderung

  • National Yang Ming Chiao Tung University
  • National Natural Science Foundation of China
  • National Science and Technology Council Taiwan
  • Brain Research Center National Yang Ming Chiao Tung University

Zitieren

APA

Ho, M. S. (2025). Clearance Pathways for α‐Synuclein in Parkinson's Disease. Journal of Neurochemistry, 169(6). https://doi.org/10.1111/jnc.70124

Vancouver

Ho MS. Clearance Pathways for α‐Synuclein in Parkinson's Disease. Journal of Neurochemistry. 2025;169(6). doi:10.1111/jnc.70124

BibTeX
@article{Ho2025,
  author = {Ho, Margaret S},
  title = {Clearance Pathways for α‐Synuclein in Parkinson's Disease},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {6},
  doi = {10.1111/jnc.70124}
}
Kostenlos starten →